search
Back to results

Esophageal Dysmotility - Prospective Study Evaluating Methods for Esophageal Dilation

Primary Purpose

Esophageal Dysmotility

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Dilation by Balloon
Dilation by Semi-rigid Savary
Sponsored by
University of Massachusetts, Worcester
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Esophageal Dysmotility

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • > 18 years old
  • Dysphagia to liquids and/or solids
  • Diagnosis of esophageal dysmotility
  • Normal endoscopic exam

Exclusion Criteria:

  • Diagnosis of achalasia
  • Defined strictures or webs
  • Vulnerable populations:
  • Adults unable to consent (Individuals who are not yet adults (infants, children, teenagers), Pregnant women, Prisoners)

Sites / Locations

  • UMass Memorial Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Dilation by Balloon

Dilation by Semi-rigid Savary

Arm Description

Esophageal dilation by balloon device.

Esophageal dilation by semi-rigid savary device.

Outcomes

Primary Outcome Measures

Therapeutic Efficacy as Measured by Change in Dysphagia Scale Score
Therapeutic efficacy of different types of dilators in an esophageal dilation procedure in patients with esophageal dysmotility. This will be evaluated through the use of the dysphagia scale (Knyrim 1993). Minimum score is 0. Maximum score is 4. Higher scores indicate a worse outcome. The data presented represent a change from baseline to 6 months calculated as the value at 6 months minus the value at baseline.

Secondary Outcome Measures

Participants With Relapse
Participants who required esophageal dilation within time frame
Time to Relapse
For the participants who relapsed, measure of time to relapse based on time from procedure to need for additional dilation due to subsidence of therapeutic effect of procedure.
Diet Dysphagia Score Change
Diet dysphagia score change based on change to Cox diet score, taken from Table 1 of publication Gut, 1988, 29, 1741-1747. The scores are determined based on the foods that cause dysphagia. The minimum value on the score is 0 (no dysphagia), followed by 1 (dysphagia with meat), 2 (dysphagia with bread), 3 (dysphagia with semi-solids), 4 (dysphagia with liquids), and the maximum score is 5 (total dysphagia). A higher score indicates a worse clinical outcome. The data presented represent a change from baseline to 6 months calculated as the value at 6 months minus the value at baseline

Full Information

First Posted
June 26, 2018
Last Updated
March 18, 2021
Sponsor
University of Massachusetts, Worcester
search

1. Study Identification

Unique Protocol Identification Number
NCT03604523
Brief Title
Esophageal Dysmotility - Prospective Study Evaluating Methods for Esophageal Dilation
Official Title
Effectiveness of Semi-rigid Savary Dilators vs. Balloon Dilators During Esophageal Dilation in the Treatment of Esophageal Dysmotility
Study Type
Interventional

2. Study Status

Record Verification Date
March 2021
Overall Recruitment Status
Terminated
Why Stopped
Slow enrollment
Study Start Date
August 14, 2014 (Actual)
Primary Completion Date
November 26, 2016 (Actual)
Study Completion Date
November 26, 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Massachusetts, Worcester

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the study is to prospectively evaluate the most effective treatment of esophageal dysmotility that alleviates symptoms of dysphagia and improves quality of life. Current practice uses either semi-rigid Savary dilators or balloon dilators for esophageal dilation to treat dysphagia due to esophageal dysmotility. The study aims to show which treatment method is more effective in alleviating symptoms, since there are no other treatments available. The null hypothesis is that there is no difference between the clinical benefits of each treatment.
Detailed Description
Both the Savary and balloon dilators are used as routine procedure at University of Massachusetts (UMass) Medical School's academic medical center UMass Memorial Health Care (UMMHC). Gastroenterologists are required as part of their training to be familiar with both types of procedures. This study aims to definitively determine which treatment method is more effective in alleviating the symptoms of esophageal dysmotility. The primary clinical endpoint is to assess the therapeutic efficacy of different types of dilators in an esophageal dilation procedure in patients with esophageal dysmotility. This will be evaluated through the use of the dysphagia scale (Knyrim et al, 1993). The secondary aims are to assess time to relapse, diet improvement, as well as change in quality of life. Investigators will determine time to relapse by time between the dilation procedures. Participants are instructed to contact the GI office to schedule another dilation if they feel as though the therapeutic effect of the procedure has subsided and they are in need of additional relief. Diet will be assessed using the diet score (Cox et al, 1998) and quality of life will be assessed using the Short Form (SF) SF-12 Health Survey. If patients fail the first procedure, they can be offered the alternative procedure at a later date. Both the patient and physician must agree that the treatment has not worked, and then the patient will be given the opportunity to cross over to the other procedure, still blinded to the device that will be used. Investigators will conduct an interim evaluation to assess the progress of the study and degree of crossover. This will ensure that all subjects are given the opportunity to have both devices used in the event that one is significantly superior to the other.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Esophageal Dysmotility

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants are randomized to procedure, but if participant fails the first procedure they are given the opportunity to crossover to the other arm for a follow up procedure.
Masking
Participant
Allocation
Randomized
Enrollment
10 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dilation by Balloon
Arm Type
Active Comparator
Arm Description
Esophageal dilation by balloon device.
Arm Title
Dilation by Semi-rigid Savary
Arm Type
Active Comparator
Arm Description
Esophageal dilation by semi-rigid savary device.
Intervention Type
Device
Intervention Name(s)
Dilation by Balloon
Intervention Description
Esophageal dilation by balloon device.
Intervention Type
Device
Intervention Name(s)
Dilation by Semi-rigid Savary
Intervention Description
Esophageal dilation by semi-rigid savary device
Primary Outcome Measure Information:
Title
Therapeutic Efficacy as Measured by Change in Dysphagia Scale Score
Description
Therapeutic efficacy of different types of dilators in an esophageal dilation procedure in patients with esophageal dysmotility. This will be evaluated through the use of the dysphagia scale (Knyrim 1993). Minimum score is 0. Maximum score is 4. Higher scores indicate a worse outcome. The data presented represent a change from baseline to 6 months calculated as the value at 6 months minus the value at baseline.
Time Frame
Baseline to 6 months post-procedure
Secondary Outcome Measure Information:
Title
Participants With Relapse
Description
Participants who required esophageal dilation within time frame
Time Frame
Baseline to 6 months
Title
Time to Relapse
Description
For the participants who relapsed, measure of time to relapse based on time from procedure to need for additional dilation due to subsidence of therapeutic effect of procedure.
Time Frame
Initial intervention to second dilation
Title
Diet Dysphagia Score Change
Description
Diet dysphagia score change based on change to Cox diet score, taken from Table 1 of publication Gut, 1988, 29, 1741-1747. The scores are determined based on the foods that cause dysphagia. The minimum value on the score is 0 (no dysphagia), followed by 1 (dysphagia with meat), 2 (dysphagia with bread), 3 (dysphagia with semi-solids), 4 (dysphagia with liquids), and the maximum score is 5 (total dysphagia). A higher score indicates a worse clinical outcome. The data presented represent a change from baseline to 6 months calculated as the value at 6 months minus the value at baseline
Time Frame
baseline to 6 months post procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: > 18 years old Dysphagia to liquids and/or solids Diagnosis of esophageal dysmotility Normal endoscopic exam Exclusion Criteria: Diagnosis of achalasia Defined strictures or webs Vulnerable populations: Adults unable to consent (Individuals who are not yet adults (infants, children, teenagers), Pregnant women, Prisoners)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David Cave, MD
Organizational Affiliation
Professor of Medicine, UMass Medical School
Official's Role
Principal Investigator
Facility Information:
Facility Name
UMass Memorial Medical Center
City
Worcester
State/Province
Massachusetts
ZIP/Postal Code
01655
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Esophageal Dysmotility - Prospective Study Evaluating Methods for Esophageal Dilation

We'll reach out to this number within 24 hrs